Where we run first-in-human trials across the Americas

The first-in-human CRO for the Americas. Where bioaccess® runs first-in-human and early feasibility trials: Mexico, Central America, the Caribbean and South America, plus an affiliated Miami cardiovascular site for Phase 1 and early device studies.

We activate the right investigators, sites and regulatory resources on demand, anywhere in the Americas, from Canada to Argentina.

bioaccess® supports medtech, biotech/biopharma and radiopharma first-in-human and early feasibility trials — devices, drugs, biologics and radiopharmaceuticals — across the Americas.

Where we run programs

• 🇺🇸 U.S. (affiliated Miami site) — Affiliated Miami cardiovascular site for Phase 1 and early device studies. FDA / IRB.
• 🇨🇴 Colombia for drugs, biologics, and vaccines — First-in-human and early feasibility programs
• 🇵🇦 Panama — First-in-human and early feasibility programs
• 🇸🇻 El Salvador — First-in-human and early feasibility programs
• 🇩🇴 the Dominican Republic — First-in-human and early feasibility programs
• 🇲🇽 Mexico — First-in-human and early feasibility programs
• 🇧🇷 Brazil — First-in-human and early feasibility programs
• 🇨🇷 Costa Rica — First-in-human and early feasibility programs
• 🇵🇾 Paraguay — First-in-human and early feasibility programs
• 🇨🇱 Chile — First-in-human study starting

Support on request

• 🇨🇦 Canada — Support on request
• 🇬🇹 Guatemala — Support on request
• 🇭🇳 Honduras — Support on request
• 🇳🇮 Nicaragua — Support on request
• 🇧🇿 Belize — Support on request
• 🇻🇪 Venezuela — Support on request
• 🇧🇴 Bolivia — Support on request
• 🇺🇾 Uruguay — Support on request
• 🇦🇷 Argentina — Support on request
• 🇵🇪 Peru — Support on request

Device registration and market access cover 19 Latin American & Caribbean countries.

First-in-Human CRO · Contact bioaccess®